104
Participants
Start Date
August 17, 2022
Primary Completion Date
February 28, 2026
Study Completion Date
February 28, 2026
JAB 21822
Administered orally
NOT_YET_RECRUITING
Research site08, Beijing
NOT_YET_RECRUITING
Research site09, Beijing
NOT_YET_RECRUITING
Research site021, Beijing
NOT_YET_RECRUITING
Research site02, Beijing
RECRUITING
Research site01, Beijing
NOT_YET_RECRUITING
Research site013, Beijing
NOT_YET_RECRUITING
Research site06, Shenyang
NOT_YET_RECRUITING
Research site07, Shenyang
NOT_YET_RECRUITING
Research site015, Changchun
NOT_YET_RECRUITING
Research site018, Harbin
NOT_YET_RECRUITING
Research site019, Hangzhou
NOT_YET_RECRUITING
Research site05, Xiamen
NOT_YET_RECRUITING
Research site010, Chongqing
NOT_YET_RECRUITING
Research site012, Changsha
NOT_YET_RECRUITING
Research site03, Hubei
NOT_YET_RECRUITING
Research site04, Zhengzhou
NOT_YET_RECRUITING
Research site011, Shenzhen
NOT_YET_RECRUITING
Research site016, Nanning
NOT_YET_RECRUITING
Research site020, Xi’an
NOT_YET_RECRUITING
Research site017, Shijiazhuang
NOT_YET_RECRUITING
Research site014, Hohhot
Lead Sponsor
Allist Pharmaceuticals, Inc.
INDUSTRY